NORDICCELL ApS: Financial statements 2018
CVR: 27293972
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 6,544,649 and a net result of DKK 1,512,902 compared with DKK 2,616,409 the year before. That is a decrease of 8.3% compared with the year before. Equity in the 2018 report amounted to DKK 2,873,078. The solvency ratio was 30.3%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 6,544,649
- Profit/Loss
- DKK 1,512,902
- Equity
- DKK 2,873,078
- Total Assets
- DKK 9,473,236
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 6.5 mio. | 1.5 mio. | 2.9 mio. | 10 |
| 2017 | - | 7.1 mio. | 2.6 mio. | 4 mio. | 9 |
| 2016 | - | 5.6 mio. | 2 mio. | 1.3 mio. | 8 |
| 2015 | - | 4.8 mio. | 1.5 mio. | 1.3 mio. | 7 |
| 2014 | - | 3.8 mio. | 1.2 mio. | 1.3 mio. | 6 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.